Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERAK: Moxifloxacin vs Amoxicillin/Clavulanate for cSSSI
NCT00828971Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in Complicated skin and skin structure infection (cSSSI), sponsored by Bayer. Started Nov 2008; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on NCT00828971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828971.